Skip to content
10-Q

Quarterly Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-12-000013

← back to feed
Filed
Apr 23, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Mar 31, 2012 11.55M sh
Operating Cash Flow Q3 2012 · Mar 31, 2012 −$1.82M
Operating Cash Flow Q3 2012 · Mar 31, 2011 −$29.15K
Operating Cash Flow Q3 2012 · Mar 31, 2011 −$101.18K
Cash And Equivalents Q3 2012 · Mar 31, 2012 $13.47K
Cash And Equivalents Q3 2012 · Jun 30, 2011 $8.68K
Stockholders Equity Q3 2012 · Mar 31, 2012 −$2.04M
Stockholders Equity Q3 2012 · Jun 30, 2011 −$1.97M
Total Liabilities Q3 2012 · Mar 31, 2012 $2.06M
Total Liabilities Q3 2012 · Jun 30, 2011 $1.98M
Current Assets Q3 2012 · Mar 31, 2012 $20.03K
Current Assets Q3 2012 · Jun 30, 2011 $16.89K
Net Income Q3 2012 · Mar 31, 2012 −$1.79M
Net Income Q3 2012 · Mar 31, 2011 −$26.96K
Net Income Q3 2012 · Mar 31, 2011 −$83.85K
Operating Income Q3 2012 · Mar 31, 2012 −$2.07M
Operating Income Q3 2012 · Mar 31, 2011 −$26.96K
Operating Income Q3 2012 · Mar 31, 2011 −$83.85K